There will be the ignorant and easily spooked mums and dads who will sell following a death during the trials, no doubt. But the grownups in the room (Instos and BP) look deeper, at the actual science. They know MPL is not a cure for MND, but rather a treatment that 'only' extends life expectancy by 3-5 years! Three to five years increased life expectancy!
When Instos & BP looks at the minimal life expectancy offered by drugs such as Riluzole (2-3 months) and Relyvrio (now pulled from market as so useless with no extended life expectancy), yet the hundreds of millions these drugs were pulling in, I don't think they're going to be spooked by a few patients passing. This is an inevitability, but the majority of patients surviving is what's more important! Most patients will take the chance they will get the extended expectancy!
- Forums
- ASX - By Stock
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
There will be the ignorant and easily spooked mums and dads who...
-
-
- There are more pages in this discussion • 269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $99.65M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.5¢ | $95.38K | 475.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 135256 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 79851 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 135256 | 0.200 |
9 | 87953 | 0.195 |
13 | 840004 | 0.190 |
12 | 226560 | 0.185 |
18 | 352803 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 79851 | 3 |
0.210 | 269460 | 5 |
0.215 | 103895 | 2 |
0.220 | 506039 | 7 |
0.225 | 420666 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |